PharmEasy-owned Thyrocare's Q1 profit soars 34% to ₹51 Cr

Thyrocare's consolidated net profit jumped 34% YoY to ₹51.3 Cr in Q1 FY27, per Inc42, as PharmEasy's diagnostics arm scales. For builders: diagnostics bundled with e-pharmacy shows unit economics work when fulfillment and testing are integrated—vertical integration in healthtech now correlates with profitability.

Source: Inc42 ↗